[CYCC] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -37.29%
YoY- 15.32%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 0 0 0 0 0 222 296 -
PBT -6,091 -2,452 -2,090 -2,354 -2,455 -3,591 -3,752 8.40%
Tax -964 -286 -307 -502 -268 -626 -405 15.53%
NP -5,127 -2,166 -1,783 -1,852 -2,187 -2,965 -3,347 7.35%
Tax Rate - - - - - - - -
Total Cost 5,127 2,166 1,783 1,852 2,187 3,187 3,643 5.85%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -1,335.59 -1,130.74 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.56 -0.56 -2.07 -3.09 -9.86 -19.77 -23.36 -46.27%
EPS Diluted -0.56 -0.56 -2.07 -3.09 -9.86 -19.77 -23.36 -46.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.